Free circulating nucleic acids in plasma and serum (CNAPS) -- Useful for the detection of lung cancer patients?

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Biomarkers

• Publication date

  2009-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/CBM-2009-0131PMID 20660966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research.

  2009cited by this paper
• Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non–Small Cell Lung Cancer Patients

  2009cited by this paper
• Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study.

  2009cited by this paper
• Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.

  2009influential reference
• Shedding microvesicles: artefacts no more.

  2009cited by this paper
• Evidence for common clonal origin of multifocal lung cancers.

  2009cited by this paper
• Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients.

  2009cited by this paper
• Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.

  2009cited by this paper
• Quantification of circulating cell‐free DNA in the plasma of cancer patients during radiation therapy

  2009cited by this paper
• Multifocal lung cancers--clonality vs field cancerization and does it matter?

  2009cited by this paper
• Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

  2008cited by this paper
• Evaluation of fluorescence-based methods for total vs. amplifiable DNA quantification in plasma of lung cancer patients.

  2008cited by this paper
• Pancreatic Metastasis From Renal Cell Carcinoma: Results of the Surgical Management and Pathologic Findings

  2008cited by this paper
• Cell‐Surface‐Bound Circulating DNA as a Prognostic Factor in Lung Cancer

  2008cited by this paper
• Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer.

  2008cited by this paper
• Comparative lesion sequencing provides insights into tumor evolution

  2008cited by this paper
• Exosomal microRNA: a diagnostic marker for lung cancer.

  2008cited by this paper
• 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.

  2008cited by this paper
• Can free DNA be detected in sputum of lung cancer patients?

  2008cited by this paper
• Plasma DNA, Microsatellite Alterations, and p53 Tumor Mutations Are Associated with Disease-Free Survival in Radically Resected Non-small Cell Lung Cancer Patients: A Study of the Perugia Multidisciplinary Team for Thoracic Oncology

  2008cited by this paper
• Exhaled breath condensate is not suitable to detect EGFR somatic mutations

  2008cited by this paper
• Is our natural-history model of lung cancer wrong?

  2008cited by this paper
• Molecular predictive factors for progression of high-grade preinvasive bronchial lesions.

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis

  2007cited by this paper
• Cancer biomarkers: current issues and future directions.

  2007cited by this paper
• Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA)

  2007cited by this paper
• Origin and prognostic value of circulating KRAS mutations in lung cancer patients.

  2007cited by this paper
• Circulating nucleic acids (CNAs) and cancer--a survey.

  2007influential reference
• High correspondence between EGFR mutations in tissue and in circulating DNA form non-small-cell lung cancer (NSCLC) patients (p) with poor performance status (PS)

  2007cited by this paper
• Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum

  2007cited by this paper
• Cell-free DNA concentration in pleural fluid and serum: quantitative approach and potential prognostic factor in patients with cancer and pleural effusions.

  2006cited by this paper
• Surveillance for the detection of early lung cancer in patients with bronchial dysplasia

  2006cited by this paper
• Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer

  2006cited by this paper
• Prognostic role of K-Ras mutations in non-small cell lung cancer: still an issue for open debate.

  2006cited by this paper
• Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: A nested case–control study

  2006cited by this paper
• KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib

  2005cited by this paper
• Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients

  2005cited by this paper
• Gene Promoter Methylation in Plasma and Sputum Increases with Lung Cancer Risk

  2005cited by this paper
• Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?

  2005cited by this paper
• 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer.

  2005cited by this paper
• Epigenetics in lung cancer: focus on progression and early lesions.

  2004cited by this paper
• Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

  2004cited by this paper
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

  2004cited by this paper
• Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients.

  2004cited by this paper
• K-ras and p16(INK4A)alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers.

  2004cited by this paper
• Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy.

  2004cited by this paper
• Premalignant evolution of lung cancer: Gilles F Filley lecture.

  2004cited by this paper
• Preinvasive bronchial lesions: surveillance or intervention?

  2004cited by this paper
• Lung cancer • 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities

  2003cited by this paper
• Quantification of free circulating DNA as a diagnostic marker in lung cancer.

  2003cited by this paper
• Towards a Genetic-Based Classification of Human Lung Cancer

  2001cited by this paper
• Predicting lung cancer by detecting aberrant promoter methylation in sputum.

  2000cited by this paper
• High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.

  2000cited by this paper
• Molecular changes in the bronchial epithelium of patients with small cell lung cancer.

  2000cited by this paper
• K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.

  1999cited by this paper
• Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours.

  1995cited by this paper
• Soluble normal and mutated DNA sequences from single-copy genes in human blood.

  1994cited by this paper
• [Diagnostic value of investigating exhaled air condensate in lung cancer].

  1994cited by this paper
• Diagnostic value of investigating exhaled air condensate in lung cancer

  1994cited by this paper
• Point mutations of the N‐ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia

  1994cited by this paper
• Les acides nucleiques du plasma sanguin chez l' homme

  1948cited by this paper

• Circulating microRNAs in Cancer: A 5-Year Update with a Focus on Breast and Lung Cancers

  2024cites this paper
• A Review of the Nucleic Acid-Based Lateral Flow Assay for Detection of Breast Cancer from Circulating Biomarkers at a Point-of-Care in Low Income Countries

  2022cites this paper
• Circulating MicroRNAs as Cancer Biomarkers in Liquid Biopsies.

  2022cites this paper
• Cancer biomarkers and their biosensors: A comprehensive review

  2022cites this paper
• Ultrasensitive and highly selective detection of PIK3CA single point mutations in cell-free DNA with LNA-modified hairpin-shaped probe

  2021cites this paper
• Plasma thymidylate synthase and dihydrofolate reductase mRNA levels as potential predictive biomarkers of pemetrexed sensitivity in patients with advanced non-small cell lung cancer

  2020cites this paper
• Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer.

  2019cites this paper
• Pathogenic Features of Liver Metastasis: The Complex Cancer Cell: Cancer Cell, and Cancer Cell – Microenvironment Interactomes

  2016cites this paper
• Expression of BKV and JCV encoded microRNA in human cerebrospinal fluid, plasma and urine.

  2015cites this paper
• DNA released by leukemic cells contributes to the disruption of the bone marrow microenvironment

  2013cites this paper
• Can quantifying free-circulating DNA in plasma be used to identify subjects with high-grade pre-invasive endobronchial lesions?

  2013cites this paper
• Sensitive detection of protein and miRNA cancer biomarkers using silicon-based photonic crystals and a resonance coupling laser scanning platform.

  2013cites this paper
• Detection of rare point mutation via allele-specific amplification in emulsion PCR

  2013cites this paper
• Electrochemiluminescent assay for detection of extremely rare mutations based on ligase reaction and bead enrichment.

  2013cites this paper
• Optimization of circulating cell-free DNA recovery for KRAS mutation and HPV detection in plasma

  2013cites this paper
• Downregulation of cell‐free miR‐198 as a diagnostic biomarker for lung adenocarcinoma‐associated malignant pleural effusion

  2013cites this paper
• The Complex Exogenous RNA Spectra in Human Plasma: An Interface with Human Gut Biota?

  2012cites this paper
• Circulating cell-free nucleic acids: promising biomarkers of hepatocellular carcinoma.

  2012cites this paper
• Runx2 mRNA expression in the tissue, serum, and circulating non-hematopoietic cells of patients with thyroid cancer.

  2012cites this paper
• Circulating MicroRNA as Biomarkers: An Update in Prostate Cancer.

  2011cites this paper
• Cell signaling molecules as drug targets in lung cancer: an overview

  2011cites this paper
• Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer

  2011cites this paper
• The MethDet: a technology for biomarker development

  2011cites this paper
• Circulating apoptotic markers in the management of non-small cell lung cancer

  2009cites this paper
• New challenges for laboratory diagnostics in non-small cell lung cancer

  2009cites this paper